Search

Search Results

• 

  Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond

  Cristina Santoro, Alessandro Casini

  03-08-2023

  https://doi.org/10.4081/btvb.2023.75

  1645

  PDF: 536
• 

  Pharmacokinetics of extended half-life albumin-fused factor IX and heterogeneous F9 variants in hemophilia B: a retrospective cohort study

  Barbara Lunghi, Massimo Morfini, Silvia Linari, Dario Balestra, Alessio Branchini, Lisa Pieri, Donata Belvini, Laura Banov, Cristina Santoro, Giancarlo Castaman, Francesco Bernardi

  02-03-2026

  https://doi.org/10.4081/btvb.2026.413

  308

  PDF: 101

  Supplementary: 65

• PO96 | Patient management with arteriovenous thrombotic manifestation and hemorrhagic complications M. Aversano, E. Cimino, L. Jr Valletta, C. Caputo, M. Romeo, M.D. Di Minno, A. Tufano, I.L. Calcaterra, C. De Luca, R. Russo, G. D’errico, P. Conca | Università degli Studi Federico II, Napoli, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.366

  529

  PDF: 0
• 

  Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention

  Marco Cattaneo

  23-06-2023

  https://doi.org/10.4081/btvb.2023.86

  1409

  PDF: 349
• 

  Diagnostic and management practices for inherited fibrinogen disorders: a nationwide survey of Italian Hemophilia Treatment Centers

  Renato Marino, Silvia Linari, Marzia Leotta, Antonio Coppola, Chiara Biasoli, Maria Elisa Mancuso, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro

  02-12-2025

  https://doi.org/10.4081/btvb.2025.372

  718

  PDF: 83

  HTML: 76

  Supplementary: 39

  Appendix: 55